Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.
Maguire S, Al-Emadi S, Alba P, Aguiar MC, Al Lawati T, Alle G, Bermas B, Bhana S, Branimir A, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, Dao K, Gianfrancesco M, Gore-Massey M, Gossec L, Grainger R, Hausman J, Hsu TYT, Hyrich K, Isnardi C, Kawano Y, Kilding R, Kusevich DA, Lawson-Tovey S, Liew J, McCarthy E, Montgumery A, Moyano S, Nasir N, Padjen I, Papagoras C, Patel NJ, Pera M, Pisoni C, Pons-Estel G, Quiambao AL, Quintana R, Ruderman E, Sattui S, Savio V, Sciascia S, Sencarova M, Morales RS, Siddique F, Sirotich E, Sparks J, Strangfeld A, Sufka P, Tanner H, Tissera Y, Wallace Z, Werner ML, Wise L, Worthing AB, Zell J, Zepa J, Machado PM, Yazdany J, Robinson P, Conway R. Maguire S, et al. Among authors: cortez kj. Rheumatology (Oxford). 2023 Apr 3;62(4):1621-1626. doi: 10.1093/rheumatology/keac534. Rheumatology (Oxford). 2023. PMID: 36124987 Free article.
Clinical characteristics and outcomes of COVID-19 patients in a tertiary hospital in Baguio City, Philippines.
Cortez KJC, Demot BA, Bartolo SS, Feliciano DD, Ciriaco VMP, Labi IIE, Viray DDM, Casuga JCM, Camonayan-Flor KAB, Gomez PMA, Velasquez MEN, Cajulao TPT, Nigos JE, De Leon MLF, Solimen DP, Go AG, Pizarro FM, Haya LC Jr, Aswat RP, Mangati VB, Palaganas CNI, Genuino MN, Cutiyog-Ubando KM, Tadeo KC, Longid ML, Catbagan NBC, Bongotan JB, Dominguez-Villar BAT, Dalao JB. Cortez KJC, et al. Western Pac Surveill Response J. 2021 Nov 11;12(4):1-11. doi: 10.5365/wpsar.2021.12.4.852. eCollection 2021 Oct-Dec. Western Pac Surveill Response J. 2021. PMID: 35251743 Free PMC article. Review.
Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective.
Zamora-Abrahan GT, Salido EO, Lichauco JJT, Gutierrez-Rubio AKM, Rivera-Go ICT, Cortez KJC, Suilan KEA, Villo JGB, Del Rosario AG. Zamora-Abrahan GT, et al. Among authors: cortez kjc. Clin Rheumatol. 2023 Apr;42(4):1171-1175. doi: 10.1007/s10067-023-06507-w. Epub 2023 Jan 13. Clin Rheumatol. 2023. PMID: 36637634 Free PMC article.
Risk Factors for Surgical Site Infections Following Anterior Cruciate Ligament Reconstruction.
Murphy MV, Du DT, Hua W, Cortez KJ, Butler MG, Davis RL, DeCoster TA, Johnson L, Li L, Nakasato C, Nordin JD, Ramesh M, Schum M, Von Worley A, Zinderman C, Platt R, Klompas M. Murphy MV, et al. Among authors: cortez kj. Infect Control Hosp Epidemiol. 2016 Jul;37(7):827-33. doi: 10.1017/ice.2016.65. Infect Control Hosp Epidemiol. 2016. PMID: 27340734
The utility of claims data for infection surveillance following anterior cruciate ligament reconstruction.
Murphy MV, Du DT, Hua W, Cortez KJ, Butler MG, Davis RL, DeCoster T, Johnson L, Li L, Nakasato C, Nordin JD, Ramesh M, Schum M, Von Worley A, Zinderman C, Platt R, Klompas M. Murphy MV, et al. Among authors: cortez kj. Infect Control Hosp Epidemiol. 2014 Jun;35(6):652-9. doi: 10.1086/676430. Epub 2014 Apr 22. Infect Control Hosp Epidemiol. 2014. PMID: 24799641
Clinical management of HIV drug resistance.
Cortez KJ, Maldarelli F. Cortez KJ, et al. Viruses. 2011 Apr;3(4):347-78. doi: 10.3390/v3040347. Epub 2011 Apr 14. Viruses. 2011. PMID: 21994737 Free PMC article. Review.
HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders do.
Osinusi A, Rasimas JJ, Bishop R, Proschan M, McLaughlin M, Murphy A, Cortez KJ, Polis MA, Masur H, Rosenstein D, Kottilil S. Osinusi A, et al. Among authors: cortez kj. J Acquir Immune Defic Syndr. 2010 Mar;53(3):357-63. doi: 10.1097/QAI.0b013e3181c7a29d. J Acquir Immune Defic Syndr. 2010. PMID: 20101190 Free PMC article. Clinical Trial.
21 results